Among these, gene fusions involving the anaplastic lymphoma kinase ( ALK ) and ROS proto-oncogene 1 ( ROS1 ), though rare, are highly significant in the context of lung cancer diagnosis and treatment 5 , 6 .
← all excerpts
Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach.
1
—
—